1. Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
One night after cell purification, HLA DR− CD69− CD25− CD4+ T cells from 4 HIV‐negative donors were mock‐treated or treated with 5‐AzadC. Three days post‐treatment, 1/3 of medium was replaced and HDACIs were added to the cultures. The median fluorescence intensity of CD4 receptor of viable CD4+ T‐cell subset was assessed 6 days after 5‐AzadC treatment by flow cytometry analysis relative to mock treatment before 5‐AzadC stimulation corresponding to day 0. Means are represented. Nonparametric one‐way ANOVA for independent samples (Kruskal–Wallis) followed by paired comparisons between each treated condition and the mock‐treated condition (Mann–Whitney test) are performed.
IF THIS IMAGE HAS BEEN PROVIDED BY OR IS OWNED BY A THIRD PARTY, AS INDICATED IN THE CAPTION LINE, THEN FURTHER PERMISSION MAY BE NEEDED BEFORE ANY FURTHER USE. PLEASE CONTACT WILEY'S PERMISSIONS DEPARTMENT ON OR USE THE RIGHTSLINK SERVICE BY CLICKING ON THE 'REQUEST PERMISSIONS' LINK ACCOMPANYING THIS ARTICLE. WILEY OR AUTHOR OWNED IMAGES MAY BE USED FOR NON-COMMERCIAL PURPOSES, SUBJECT TO PROPER CITATION OF THE ARTICLE, AUTHOR, AND PUBLISHER.
EMBO Mol Med, Volume: 8, Issue: 2, Pages: , First published: 17 December 2015, DOI: ( /emmm )